Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading

MT Newswires Live06-17

Bank stocks were helping European equities traded in the US as American depositary receipts nudge marginally higher late Monday morning, rising 0.047% to 1,409.42 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by financial services company ING (ING) and pharmaceutical company Sanofi (SNY), which rose 2.9% and 1.7% respectively. They were followed by financial services company Banco Santander (SAN) and biopharmaceutical company DBV Technologies (DBVT), which were up 1.5% and 1% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX), which tumbled 20.5%, followed by biopharmaceutical company Cellectis (CLLS), which fell 5.8%. They were followed by biotech firm BioNTech (BNTX) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.6% each.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and Mereo BioPharma Group (MREO), which climbed 10.2% and 4% respectively. They were followed by construction materials supplier CRH (CRH) and financial services company Lloyds Banking Group (LYG), which increased 1.2% and 0.9% respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and pharmaceutical company Silence Therapeutics (SLN), which dropped 13.7% and 2% respectively. They were followed by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which lost 2.9% and 2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment